Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia(Icahn School of Medicine at Mount Sinai), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Helena Cornellà(Universitat de Barcelona), Joana Ferrer(Instituto de Salud Carlos III), Clara Alsinet(Hospital Clínic de Barcelona), Rameen Beroukhim(Broad Institute), Jian‐Bing Fan(Southern Medical University), Judit Peix, Victoria Tovar(Hospital Clínic de Barcelona), Augusto Villanueva(NYU Langone Health), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Manel Solé(Hospital Clínic de Barcelona), Christian Cotsoglou(National Cancer Institute), Barbara Tabak, Josep Fuster(Hospital Universitario Son Espases), Jordi Bruix(Hospital Clínic de Barcelona), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Brandy Klotzle(Illumina (United States)), Samuel Waxman(Icahn School of Medicine at Mount Sinai), Juan Carlos García‐Valdecasas(Hospital Clínic de Barcelona), Yujin Hoshida(Broad Institute), Sasan Roayaie(White Plains Hospital), Myron Schwartz(Icahn School of Medicine at Mount Sinai)
Cited by 597
Related Papers
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k